Suppression of pokeweed mitogen-driven human IgM and IgG responses by the hydroxylamine of sulfamethoxazole

International Journal of Immunopharmacology

Volumn 19, Issue 5, 1997, Pages 299-304

  Sisson, M Erin ^a   Rieder, Michael J ^a   Bird, Ingrid A ^a   Almawi, Wassim Y ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Adverse drug reactions; IgG; IgM; Sulfonamides

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; SULFONAMIDE;

ANTIBODY PRODUCTION; ARTICLE; BLOOD; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERSENSITIVITY REACTION; IMMUNITY; PERIPHERAL BLOOD STEM CELL; POKEWEED; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; ANTIBODY FORMATION; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; POKEWEED MITOGENS; SULFAMETHOXAZOLE;

EID: 0030813240     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(97)00027-1     Document Type: Article

References (22)

1. Cribb, A. E. & Spielberg, S. P. (1990) Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. Drug. Metabol. Disp., 18, 784-787.
2. Cribb, A. E. & Spielberg, S. P. (1992) Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin. Pharmacol. Ther., 51, 522-526.
3. Hughes, W. T., Riveria, G. K., Schell, M. J., Thornton, D. & Lott, L. (1987) Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonia. N. Engl. J. Med., 316, 1627-1632.
4. Hughes, W. T., Feldman, S., Chaudhary, S. C., Ossi, M. J., Cox, F. & Sanyal, S. K. (1978) Comparison of pentamidine kethionale and trimethoprim-sulfamethoxazole in the treatment of Pneumocystitis carinii pneumonia. J. Pediatr., 92, 285-289.
5. Kaplan, A. P. (1984) Drug-induced skin disease. J. Allergy Clin. Immunol., 74, 573-579.
6. Lee, B., Wong, D., Benowitz, N. L. & Sullam, P. M. (1993) Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin. Pharmacol. Ther., 53, 529-535.
7. Leeder, N. S., Nakhooda, A., Spielberg, S. P. & Dosch, H. -M. (1991) Cellular toxicity of sulfamethoxazole reactive metabolites - II - inhibition of natural killer cell activity in human peripheral blood mononuclear cells. Biochem. Pharmacol., 41, 575-583.
8. Medina, I., Mills, J., Leoung, G., Hopewell, P. C., Lee, B. & Modin, G. (1990) Oral therapy for Pneumocystisis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N. Engl. J. Med., 92, 776-782.
9. Park, B. K., Coleman, J. W., Kitteringham, N. R. (1987) Drug disposition and drug hypersensitivity. Biochem. Pharmacol., 36, 581-589.
10. Park, B. K., Kitteringham, N. R. (1990) Drug-protein conjugation and its immunological consequences. Drug Metabol. Rev., 22, 87-144.
11. Rieder, M. J., Uetrecht, J., Shear, N. H. & Spielberg, S. P. (1988) Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J. Pharmacol. Exp. Ther., 244, 724-728.
12. Rieder, M. J., Uetrecht, J., Shear, N. H., Cannon, M., Miller, M. & Spielberg, S. P. (1989) Diagnosis of sulphonamide hypersensitivity reactions by in vitro "rechallenge" with hydroxylamine metabolites. Ann. Intern. Med., 110, 286-289.
13. Rieder, M. J., Mask, M. & Bird, I. A. (1992) Production of tumour necrosis factor by cells exposed to sulphonamide reactive metabolites. Can. J. Physiol. Pharmacol., 70, 719-722.
14. Rieder, M. J., Sisson, E., Bird, I. A. & Almawi, Y. (1992) Suppression of T lymphocyte proliferation by sulphonamide hydroxylamines. Int. J. Immunopharmacol., 14, 1175-1180.
15. Rieder, M. J., Krause, R., Bird, I. A. & Dekaban, G. (1995) Toxicity of sulphonamide reactive metabolites in HIV-infected and non-infected cells. J. AIDS, 8, 134-140.
16. Rieder, M. J., Krause, R. & Bird, I. A. (1995) Time-course of toxicity of reactive sulfonamide metabolites. Toxicol., 95, 141-146.
17. Ruskin, J. & LaRiviere, M. (1991) Low-dose co-trimoxazole for prevention of Pneumocystitis carinii pneumonia in human immunodeficiency disease. Lancet, 337, 468-471.
18. Shear, N. H. & Spielberg, S. P. (1986) In vitro evaluation of a toxic metabolite of sulfadiazine. Can. J. Physiol. Pharmacol., 63, 1370-1372.
19. Shear, N. H., Spielberg, S. P., Grant, D. M., Tang, B. K. & Kalow, W. (1986) Differences in metabolism predisposing to idiosyncratic toxicity. Ann. Intern. Med., 105, 179-184.
20. Voller, A., Bidwell, D. & Bartlett, A. (1980) Enzyme-linked immunosorbent assay. In Manual of Clinical Immunology, 2nd edn (eds Rose, N. F. and Friedman, H.) pp. 359-371. American Society of Microbiology, Washington, DC.
21. Warren, J. S. (1990) Interleukins and tumour necrosis factor in inflammation. Crit. Rev. Clin. Lab. Sci., 28, 37-57.
22. Weiss, A. (1989) Lymphocyte activation. In Fundamental Immunology, 2nd edn (ed. Paul, W. E.) pp. 359-384. Raven Press, New York.